| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Department of Physiology, Nippon Medical School (K.A., T.S.), 11-5 Sendagi, Bunkyo-ku, Tokyo 113-8602, Japan; and the Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health (K.Z., G.P.C.), Bethesda, Maryland 20892
Address all correspondence and requests for reprints to: Keiko Arai, M.D., Department of Physiology, Nippon Medical School, 11-5 Sendagi, Bunkyo-ku, Tokyo 113-8602, Japan. E-mail: arai_keiko/phys2{at}nms.ac.jp
Pseudohypoaldosteronism (PHA) is characterized by congenital resistance
of the kidney and/or other mineralocorticoid target tissues to
aldosterone, resulting in excessive salt wasting. Mineralocorticoid
receptor (MR) and postreceptor defects in the aldosterone-responsive
amiloride-sensitive sodium channel (ENaC) subunits have been suggested
as potential loci of the defect in this disease, whereas recently
defects in MR and ENaC subunits were reported in familial PHA cases.
Here we studied the ENaC subunit
, ß, and
complementary DNAs
(cDNAs) in a series of five sporadic cases of PHA, whose MR cDNA
contained nonconservative homozygous
(C944
T944,
Ala241
Val241) and/or a conservative
heterozygous substitutions (A760
G760,
Ileu180
Val180), which, however, were also
present at high frequencies in a control population with apparently
normal salt conservation. We found a nonconservative substitution
(A2086
G2086,
Thr663
Ala663) in the
ENaC in all five of
our patients, two of whom were homozygous and three of whom were
heterozygous for this alteration, which was also present in the
homozygous and heterozygous form in 31% and 64% of control subjects,
respectively. We also found a nonconservative homozygous substitution
(C1006
G1006,
Pro336
Ara336) in the ßENaC and three
nonconservative and conservative homozygous substitutions
(T554
A554,
Trp178
Arg178;
C1526
G1526,
Pro501
Ala501;
T1862
G1862,
Ser614
Ala614) in the
ENaC of all five of
our patients and in a substantial proportion of control subjects.
Interestingly, when the patient group was compared to controls, a
significantly increased concurrence of the MR and
ENaC polymorphisms
was found in the patients (P < 0.025). We conclude
that the changes identified in the cDNA of the three ENaC subunits in
the patients with sporadic PHA are polymorphisms, which on their own
have no apparent pathophysiological significance. We hypothesize,
however, that these polymorphisms might influence salt conservation
negatively if they are present concurrently with other genetic defects
of the MR or other proteins that participate in sodium homeostasis. The
latter would be compatible with a sporadic presentation and digenic or
multigenic expression and heredity in PHA.
This article has been cited by other articles:
![]() |
A. Balsamo, A. Cicognani, M. Gennari, W. G Sippell, S. Menabo, F. Baronio, and F. G Riepe Functional characterization of naturally occurring NR3C2 gene mutations in Italian patients suffering from pseudohypoaldosteronism type 1 Eur. J. Endocrinol., February 1, 2007; 156(2): 249 - 256. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lebowitz, R. S. Edinger, B. An, C. J. Perry, S. Onate, T. R. Kleyman, and J. P. Johnson I{kappa}B Kinase-{beta} (IKK{beta}) Modulation of Epithelial Sodium Channel Activity J. Biol. Chem., October 1, 2004; 279(40): 41985 - 41990. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-M. Nystrom, M.-L. Bondeson, N. Skanke, J. Martensson, B. Stromberg, J. Gustafsson, and G. Anneren A Novel Nonsense Mutation of the Mineralocorticoid Receptor Gene in a Swedish Family with Pseudohypoaldosteronism Type I (PHA1) J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 227 - 231. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G. Riepe, N. Krone, M. Morlot, M. Ludwig, W. G. Sippell, and C.-J. Partsch Identification of a Novel Mutation in the Human Mineralocorticoid Receptor Gene in a German Family with Autosomal-Dominant Pseudohypoaldosteronism Type 1: Further Evidence for Marked Interindividual Clinical Heterogeneity J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1683 - 1686. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Thomas, J. Zhou, K. Z. Liu, V. E. Mick, E. MacLaughlin, and M. Knowles Systemic Pseudohypoaldosteronism from Deletion of the Promoter Region of the Human {beta} Epithelial Na+ Channel Subunit Am. J. Respir. Cell Mol. Biol., September 1, 2002; 27(3): 314 - 319. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Bonny and B. C. Rossier Disturbances of Na/K Balance: Pseudohypoaldosteronism Revisited J. Am. Soc. Nephrol., September 1, 2002; 13(9): 2399 - 2414. [Full Text] [PDF] |
||||
![]() |
A. Saxena, I. Hanukoglu, D. Saxena, R. J. Thompson, R. M. Gardiner, and A. Hanukoglu Novel Mutations Responsible for Autosomal Recessive Multisystem Pseudohypoaldosteronism and Sequence Variants in Epithelial Sodium Channel {alpha}-, {beta}-, and {gamma}-Subunit Genes J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3344 - 3350. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-Z. Xue, O. Bonny, S. Morgenthaler, M. Bochud, V. Mooser, W. G. Thilly, L. Schild, and P.-M. Leong-Morgenthaler Use of Constant Denaturant Capillary Electrophoresis of Pooled Blood Samples to Identify Single-Nucleotide Polymorphisms in the Genes (Scnn1a and Scnn1b) Encoding the {alpha} and {beta} Subunits of the Epithelial Sodium Channel Clin. Chem., May 1, 2002; 48(5): 718 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Viemann, M. Peter, J. P. López-Siguero, G. Simic-Schleicher, and W. G. Sippell Evidence for Genetic Heterogeneity of Pseudohypoaldosteronism Type 1: Identification of a Novel Mutation in the Human Mineralocorticoid Receptor in one Sporadic Case and No Mutations in Two Autosomal Dominant Kindreds J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2056 - 2059. [Abstract] [Full Text] |
||||
![]() |
M. Adachi, K. Tachibana, Y. Asakura, S. Abe, J. Nakae, T. Tajima, and K. Fujieda Compound Heterozygous Mutations in the {{gamma}} Subunit Gene of ENaC (1627delG and 1570-1G{->}A) in One Sporadic Japanese Patient with a Systemic Form of Pseudohypoaldosteronism Type 1 J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 9 - 12. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |